Christian Martin Tegeler (Christian M Tegeler)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Early Breast Cancer

Respiratory Syndrome Coronavirus

Natural Killer Cells

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Anna Seller, Christian Martin Tegeler, Jonas Mauermann, Tatjana Schreiber, Ilona Hagelstein, Kai Liebel, André Koch, Jonas S Heitmann, Sarah M Greiner, Clara Hayn, Dominik Dannehl, Tobias Engler, Andreas Daniel Hartkopf, Markus Hahn, Sara Yvonne Brucker, Helmut R Salih, Melanie Märklin
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome. International journal of molecular sciences 25 (7) (2024)
Christopher Hackenbruch, Yacine Maringer, Christian Martin Tegeler, Juliane Sarah Walz, Annika Nelde, Jonas S Heitmann
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome. Viruses 15 (3) (2023)
Christopher Hackenbruch, Yacine Maringer, Christian Martin Tegeler, Juliane Sarah Walz, Annika Nelde, Jonas S Heitmann
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome. Viruses 15 (3) (2023)
Dominik Dannehl, Tobias Engler, Léa Louise Volmer, Christian Martin Tegeler, Julia Fusshoeller, Emma Gabrysch, Kenneth Eissler, Anna Seller, Eva-Maria Grischke, Markus Hahn, Ines Gruber, Fabienne Schochter, Kerstin Pfister, Kristina Veselinovic, Elena Leinert, Brigitte Rack, Visnja Fink, Wolfgang Janni, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Henning Schäffler
Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers. Cancers 15 (15) (2023)
Polina Kaidun, Samuel J Holzmayer, Sarah M Greiner, Anna Seller, Christian Martin Tegeler, Ilona Hagelstein, Jonas Mauermann, Tobias Engler, André Koch, Andreas Daniel Hartkopf, Helmut R Salih, Melanie Märklin
Targeting NKG2DL with Bispecific NKG2D-CD16 and NKG2D-CD3 Fusion Proteins on Triple-Negative Breast Cancer. International journal of molecular sciences 24 (17) (2023)
Henning Schäffler, Franziska Mergel, Kerstin Pfister, Stephan Lukac, Angelina Fink, Kristina Veselinovic, Brigitte Rack, Visnja Fink, Elena Leinert, Moritz Dimpfl, Alexander Englisch, Christian Martin Tegeler, Anna Seller, Eva-Maria Grischke, Markus Hahn, Léa Louise Volmer, Tobias Engler, Marie Louise Frevert, Florin-Andrei Taran, Wolfgang Janni, Sara Yvonne Brucker, Andreas Daniel Hartkopf, Dominik Dannehl
The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers. International journal of molecular sciences 24 (22) (2023)
Christopher Hackenbruch, Yacine Maringer, Christian Martin Tegeler, Juliane Sarah Walz, Annika Nelde, Jonas S Heitmann
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome. Viruses 15 (3) (2023)
Christian Martin Tegeler, Jonas Scheid, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz, Jonas S Heitmann, Annika Nelde
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients. Cancers 14 (9) (2022)